TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05026749: Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children

Sponsor: University of Alabama at Birmingham · Phase: PHASE3 · Area: INFECTIOUS_VACCINE · Target Enrollment: 370 pts

Competing Trials Overlap

10 Active Trials

Excess Burn Exposure

$2,296,140

Rescue Site Savings

+$1,502,928

Unlock Full NCT05026749 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05026749 Rescue Dossier →